Proper Dietary Management, Follow-up, and Lactase Enzyme Supplementation for Lactose Intolerance

Recruiting

• Conditions: Lactose Malabsorption; Lactose Intolerance; Lactose Intolerant

• Registration Number: NCT06773650
• Lead Sponsor: European Institute of Oncology

Brief Summary

Lactose intolerance (LI) is considered the clinical syndrome caused by lactose malabsorption (LM).

It is possible to identify four causes of lactase deficiency defining four different types of LM: primary (genetic), secondary (acquired), congenital (alactasia), and developmental (in premature infants, so reversible).

The aim of this protocol is to investigate through an anonymous online survey the knowledge of the Italian population on clinical, pathophysiological, diagnostic and therapeutic issues of lactose intolerance. Data collected will be divulgated through a publication for both people with IL and nutritionists, enriched with tables and flow charts, to improve the knowledge on lactose intolerance and to support people suffering from this condition. The results of this survey will guide subjects suspected of suffering from lactose intolerance towards a correct diagnosis and a better management.

Detailed Description

Not available

Study Timeline

• Status Verified: 2025-01
• Study Start: 2025-01-08
• Study First Submitted: 2025-01-09
• Study First Submitted QC: 2025-01-09
• Last Update Submitted: 2025-01-09
• Study First Posted: 2025-01-14
• Last Update Posted: 2025-01-14
• Primary Completion: 2026-01
• Study Completion: 2026-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 385

Inclusion Criteria

• Subjects must be adults (≥18 years of age)
• Willingness to complete the online survey

Exclusion Criteria

• Subjects <18 years of age
• Subjects not available to answer the online survey

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evaluation of knowledge of the Italian population on lactose intolerance	3 months	The aim of this protocol is to investigate through an anonymous online survey the knowledge of the Italian population on clinical, pathophysiological, diagnostic and therapeutic issues of lactose intolerance

Trial Locations

Locations (1)

European Institute of Oncology; 🇮🇹 Milan, Italy